Similarly, MMRd ECs are enriched in CD8+ T cells expressing high levels of PD-1, CD39, TIM-3 and CXCL13, which define a population of tumor-reactive T cells that was also positively correlated with the level of the TMB (160) (Figure 2). The gene discussed is CD8A; the disease is neoplasm.